Centers for Medicare and Medicaid Services (CMS) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Medicare Anti-A β mAb Coverage With Evidence Development (CED) Study
Conditions: Mild Alzheimer's Disease; Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease Intervention: Drug: Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Sponsor: Centers for Medicare and Medicaid Services/ Coverage and Analysis Group Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Medicare Anti-A β mAb Coverage With Evidence Development (CED) Study
Conditions: Mild Alzheimer ' s Disease; Mild Cognitive Impairment (MCI) Due to Alzheimer ' s Disease Interventions: Drug: Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer ' s Disease Sponsors: Centers for Medicare and Medicaid Services/ Coverage and Analysis Group Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Centers for Medicare and Medicaid Services (CMS) Has Established Permanent Billing Codes for the NovoTTF-100A System™
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - December 18, 2013 Category: Cancer & Oncology Source Type: clinical trials
